MHRA Appoints New Chief Executive
News Jul 05, 2013
He will take up the post in September when current Chief Executive Sir Kent Woods steps down, after ten years with the agency.
Dr Hudson is currently the MHRA’s Licensing Director, responsible for the majority of medicines licensing activities. He is the UK delegate to the Committee on Human Medicinal Products (CHMP) at the European Medicines Agency and has been its vice-chairman since October 2012.
In line with Government protocol, the Department of Health officially announced the appointment and their press release is available through the link below.
Animal venoms are the subject of study at research center based at the Butantan Institute in São Paulo. But in this case, the idea is not to find antidotes, but rather to use the properties of the venoms themselves to identify molecular targets of diseases and, armed with that knowledge, develop new compounds that can be used as medicines.